ASLAN Pharmaceuticals Limited (ASLN)
NASDAQ: ASLN · IEX Real-Time Price · USD
0.600
-0.100 (-14.27%)
At close: Jul 18, 2024, 4:00 PM
0.560
-0.040 (-6.67%)
After-hours: Jul 18, 2024, 7:58 PM EDT
ASLAN Pharmaceuticals Market Cap
ASLAN Pharmaceuticals has a market cap or net worth of $2.69 million as of July 22, 2024. Its market cap has decreased by -95.61% in one year.
Market Cap
2.69M
Enterprise Value
10.96M
1-Year Change
-95.61%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since May 4, 2018, ASLAN Pharmaceuticals's market cap has decreased from $188.10M to $2.69M, a decrease of -98.57%. That is a compound annual growth rate of -49.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2024 | 1.40M | -84.44% |
| Dec 29, 2023 | 9.00M | -64.14% |
| Dec 30, 2022 | 25.10M | -67.82% |
| Dec 31, 2021 | 78.00M | 12.23% |
| Dec 31, 2020 | 69.50M | 6.76% |
| Dec 31, 2019 | 65.10M | -46.06% |
| Dec 31, 2018 | 120.70M | -35.83% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 2.97M |
| INVO Bioscience | 2.85M |
| TC Biopharm (Holdings) | 2.82M |
| Virax Biolabs Group | 2.76M |
| Revelation Biosciences | 2.74M |
| Altamira Therapeutics | 2.69M |
| FOXO Technologies | 2.64M |
| Cingulate | 2.56M |